Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort
Journal of Obesity · 06.10.2021 · 2021 · 1-9
DOI: 10.1155/2021/6616983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obesity, erschienen am 06.10.2021. Verfasst von J Korduner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Metabolic Syndrome, Obesity, Metabolically Benign. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Swedish Foundation for Strategic Research, Swedish Research Council.
Abstract (Originalsprache)
Background/Aims. Obesity is a well-established risk factor for the development of numerous chronic diseases. However, there is a small proportion of obese individuals that seem to escape these aforementioned conditions—Metabolically Healthy Obesity (MHO). Our aim was to do a metabolic and biomarker profiling of MHO individuals.
Method
Associations between different biomarkers (proteomics, lipidomics, and metabolomics) coupled to either MHO or metabolically unhealthy obese (MUO) individuals were analyzed through principal component analysis (PCA). Subjects were identified from a subsample of 416 obese individuals, selected from the Malmö Diet and Cancer study—Cardiovascular arm (MDCS-CV, n = 3,443). They were further divided into MHO (n = 143) and MUO (n = 273) defined by a history of hospitalization, or not, at baseline inclusion, and nonobese subjects (NOC, n = 3,027). Two distinctive principle components (PL2, PP5) were discovered with a significant difference and thus further investigated through their main loadings.
Results
MHO individuals had a more metabolically favorable lipid and glucose profile than MUO subjects, that is, lower levels of traditional blood glucose and triglycerides, as well as a trend of lower metabolically unfavorable lipid biomarkers. PL2 (lipidomics, p = 0.02 ) showed stronger associations of triacylglycerides with MUO, whereas phospholipids correlated with MHO. PP5 (proteomics, p = 0.01 ) included interleukin-1 receptor antagonist (IL-1ra) and leptin with positive relations to MUO and galanin that correlated positively to MHO. The group differences in metabolite profiles were to a large extent explained by factors included in the metabolic syndrome.
Conclusion
Compared to MUO individuals, corresponding MHO individuals present with a more favorable lipid metabolic profile, accompanied by a downregulation of potentially harmful proteomic biomarkers. This unique and extensive biomarker profiling presents novel data on potentially differentiating traits between these two obese phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Sciences, Lund University, Malmö, Sweden.
- Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
- Lipotype GmbH, Dresden, Germany.
- Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
- Department of Cardiology, Skåne University Hospital, Malmö, Sweden.
- North-West University, Hypertension in Africa Research Team (HART), Potchefstroom, South Africa.
ORCID-Profile: J Korduner, P M Nilsson, O Melander, M J Gerl, G Engström, E Bachus, M Magnusson, F Ottosson
Förderung
- European Research Council
- Swedish Foundation for Strategic Research
- Swedish Research Council
Zitieren
APA
Korduner, J., Nilsson, P. M., Melander, O., Gerl, M. J., Engström, G., Bachus, E., Magnusson, M., & Ottosson, F. (2021). Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort. Journal of Obesity, 2021, 1-9. https://doi.org/10.1155/2021/6616983
Vancouver
Korduner J, Nilsson PM, Melander O, Gerl MJ, Engström G, Bachus E, et al. Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort. Journal of Obesity. 2021;2021:1-9. doi:10.1155/2021/6616983
BibTeX
@article{Korduner2021,
author = {Korduner, J and Nilsson, P M and Melander, O and Gerl, M J and Engström, G and Bachus, E and Magnusson, M and Ottosson, F},
title = {Proteomic and Metabolomic Characterization of Metabolically Healthy Obesity: A Descriptive Study from a Swedish Cohort},
journal = {Journal of Obesity},
year = {2021},
volume = {2021},
pages = {1--9},
doi = {10.1155/2021/6616983}
}
EUVIMED